Fibrocell Science (FCSC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Operating Expenses | 3,077 | 2,981 | 4,904 | 4,596 | 5,027 |
| Operating Income | -3,077 | -2,981 | -4,904 | -4,596 | -5,027 |
| Interest Expense | 191 | 190 | 187 | 273 | 185 |
| Other Income | 374 | 270 | 7,991 | 4,754 | -8,806 |
| Pre-tax Income | -2,894 | -2,901 | 2,900 | -115 | -14,018 |
| Net Income Continuous | -2,894 | -2,901 | 2,900 | -115 | -14,018 |
| Net Income | $-2,894 | $-2,901 | $2,900 | $-115 | $-14,018 |
| EPS Basic Total Ops | -0.49 | -0.55 | 1.28 | -0.10 | -4.84 |
| EPS Basic Continuous Ops | -0.45 | -0.51 | 1.26 | -0.04 | -4.77 |
| EPS Diluted Total Ops | -0.49 | -0.55 | 1.29 | -0.12 | -4.84 |
| EPS Diluted Continuous Ops | -0.45 | -0.51 | 1.26 | -0.04 | -4.77 |
| EPS Diluted Before Non-Recurring Items | -0.49 | -0.55 | -3.25 | N/A | N/A |
| EBITDA(a) | $-2,976 | $-2,880 | $-4,802 | $-4,412 | $-4,934 |